company background image
UCM

Uscom ASX:UCM Stock Report

Last Price

AU$0.051

Market Cap

AU$10.1m

7D

0%

1Y

-51.4%

Updated

03 Feb, 2023

Data

Company Financials

UCM Stock Overview

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide.

UCM fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Uscom Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Uscom
Historical stock prices
Current Share PriceAU$0.051
52 Week HighAU$0.11
52 Week LowAU$0.044
Beta-0.82
1 Month Change13.33%
3 Month Change2.00%
1 Year Change-51.43%
3 Year Change-83.81%
5 Year Change-78.30%
Change since IPO-97.88%

Recent News & Updates

Recent updates

Uscom Limited (ASX:UCM) Insiders Increased Their Holdings

Jan 25
Uscom Limited (ASX:UCM) Insiders Increased Their Holdings

Key Things To Understand About Uscom's (ASX:UCM) CEO Pay Cheque

Dec 01
Key Things To Understand About Uscom's (ASX:UCM) CEO Pay Cheque

Shareholder Returns

UCMAU Medical EquipmentAU Market
7D0%3.4%0.5%
1Y-51.4%5.3%2.1%

Return vs Industry: UCM underperformed the Australian Medical Equipment industry which returned 5.3% over the past year.

Return vs Market: UCM underperformed the Australian Market which returned 2.1% over the past year.

Price Volatility

Is UCM's price volatile compared to industry and market?
UCM volatility
UCM Average Weekly Movementn/a
Medical Equipment Industry Average Movement10.0%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.7%
10% least volatile stocks in AU Market3.4%

Stable Share Price: Insufficient data to determine UCM's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine UCM's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199935Rob Phillipshttps://www.uscom.com.au

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company also provides the SpiroSonic AIR, a digital multipath ultrasonic spirometer with a viral disinfection system for the elimination of COVID and tuberculosis; and respiratory devices.

Uscom Limited Fundamentals Summary

How do Uscom's earnings and revenue compare to its market cap?
UCM fundamental statistics
Market CapAU$10.13m
Earnings (TTM)-AU$1.97m
Revenue (TTM)AU$3.25m

3.1x

P/S Ratio

-5.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
UCM income statement (TTM)
RevenueAU$3.25m
Cost of RevenueAU$344.47k
Gross ProfitAU$2.91m
Other ExpensesAU$4.88m
Earnings-AU$1.97m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.0099
Gross Margin89.41%
Net Profit Margin-60.62%
Debt/Equity Ratio0%

How did UCM perform over the long term?

See historical performance and comparison